What is the share price of RPG Life Sciences Limited (RPGLIFE) today?
The share price of RPGLIFE as on 17th April 2025 is ₹2201.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on RPG Life Sciences Limited (RPGLIFE) share?
The past returns of RPG Life Sciences Limited (RPGLIFE) share are- Past 1 week: 8.52%
- Past 1 month: 3.86%
- Past 3 months: 5.73%
- Past 6 months: -21.25%
- Past 1 year: 45.68%
- Past 3 years: 265.11%
- Past 5 years: 823.19%
What are the peers or stocks similar to RPG Life Sciences Limited (RPGLIFE)?
The peers or stocks similar to RPG Life Sciences Limited (RPGLIFE) include:What is the dividend yield % of RPG Life Sciences Limited (RPGLIFE) share?
The current dividend yield of RPG Life Sciences Limited (RPGLIFE) is 0.73.What is the market cap of RPG Life Sciences Limited (RPGLIFE) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of RPG Life Sciences Limited (RPGLIFE) is ₹3632.75 Cr as of 17th April 2025.What is the 52 week high and low of RPG Life Sciences Limited (RPGLIFE) share?
The 52-week high of RPG Life Sciences Limited (RPGLIFE) is ₹2974.95 and the 52-week low is ₹1381.What is the PE and PB ratio of RPG Life Sciences Limited (RPGLIFE) stock?
The P/E (price-to-earnings) ratio of RPG Life Sciences Limited (RPGLIFE) is 41.44. The P/B (price-to-book) ratio is 9.69.Which sector does RPG Life Sciences Limited (RPGLIFE) belong to?
RPG Life Sciences Limited (RPGLIFE) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy RPG Life Sciences Limited (RPGLIFE) shares?
You can directly buy RPG Life Sciences Limited (RPGLIFE) shares on Tickertape. Simply sign up, connect your demat account and place your order.
RPG Life Sciences Limited
RPGLIFE Share Price
RPGLIFE Share Price Chart
How to use scorecard? Learn more
RPGLIFE Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
45.91 | 9.69 | 0.73% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
49.39 | 6.29 | 0.54% |
RPGLIFE Analyst Ratings & Forecast
Detailed Forecast Price Upside
Earnings Growth
Rev. Growth
RPGLIFE Company Profile
RPG Life Sciences Limited is engaged in manufacturing and marketing of pharmaceutical products. The Company operates across segments, including Domestic Formulations, International Formulations, Active Pharmaceutical Ingredients (API) and Biotech.
Investor Presentation
View olderRPGLIFE Similar Stocks (Peers)
Compare with peersRPGLIFE Forecasts
Price
Revenue
Earnings
RPGLIFE Share Price Forecast
RPGLIFE Company Revenue Forecast
RPGLIFE Stock EPS (Earnings Per Share) Forecast
RPGLIFE
Income
Balance Sheet
Cash Flow
RPGLIFE Income Statement
Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 280.10 | 303.17 | 344.93 | 330.96 | 376.30 | 390.05 | 443.15 | 517.61 | 589.26 | 646.60 | ||||||||||
Raw Materials | 93.85 | 112.21 | 121.30 | 96.33 | 133.74 | 136.11 | 167.03 | 178.17 | 181.83 | 509.75 | ||||||||||
Power & Fuel Cost | 11.23 | 9.10 | 10.44 | 10.38 | 11.54 | 11.27 | 12.69 | 13.65 | 14.36 | |||||||||||
Employee Cost | 74.13 | 75.59 | 90.14 | 89.93 | 90.97 | 94.66 | 99.97 | 117.06 | 132.15 | |||||||||||
Selling & Administrative Expenses | 38.80 | 55.41 | 63.13 | 59.43 | 56.84 | 58.40 | 67.07 | 73.63 | 80.47 | |||||||||||
Operating & Other expenses | 37.83 | 12.45 | 20.50 | 39.66 | 27.64 | 17.77 | 6.15 | 26.77 | 44.10 | |||||||||||
EBITDA | 24.26 | 38.41 | 39.42 | 35.23 | 55.57 | 71.84 | 90.24 | 108.33 | 136.35 | 136.85 | ||||||||||
Depreciation/Amortization | 10.15 | 11.31 | 14.34 | 15.32 | 16.36 | 16.47 | 15.66 | 15.50 | 17.07 | 20.55 | ||||||||||
PBIT | 14.11 | 27.10 | 25.08 | 19.91 | 39.21 | 55.37 | 74.58 | 92.83 | 119.28 | 116.30 | ||||||||||
Interest & Other Items | 2.49 | 3.64 | 4.72 | 4.86 | 2.76 | 1.79 | 1.41 | 1.15 | 1.44 | 0.58 | ||||||||||
PBT | 11.62 | 23.46 | 20.36 | 15.05 | 36.45 | 53.58 | 73.17 | 91.68 | 117.84 | 115.72 | ||||||||||
Taxes & Other Items | 0.00 | 2.45 | 6.91 | 4.24 | 7.44 | 13.58 | 21.69 | 24.04 | 30.18 | 36.59 | ||||||||||
Net Income | 11.62 | 21.01 | 13.45 | 10.81 | 29.01 | 40.00 | 51.48 | 67.64 | 87.66 | 79.13 | ||||||||||
EPS | 7.03 | 12.70 | 8.13 | 6.54 | 17.54 | 24.19 | 31.13 | 40.90 | 53.00 | 47.84 | ||||||||||
DPS | 1.60 | 2.80 | 2.40 | 2.40 | 4.00 | 7.20 | 9.60 | 12.00 | 16.00 | 16.00 | ||||||||||
Payout ratio | 0.23 | 0.22 | 0.30 | 0.37 | 0.23 | 0.30 | 0.31 | 0.29 | 0.30 | 0.33 |
RPGLIFE Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
RPGLIFE Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
RPG Life Sciences Limited | 41.44 | 9.69 | 0.73% |
Sun Pharmaceutical Industries Ltd | 43.78 | 6.25 | 0.77% |
Cipla Ltd | 29.62 | 4.55 | 0.86% |
Torrent Pharmaceuticals Ltd | 66.34 | 16.03 | 0.86% |
RPGLIFE Stock Price Comparison
Compare RPGLIFE with any stock or ETFRPGLIFE Shareholdings
RPGLIFE Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
RPGLIFE Institutional Holdings Trend
In last 3 months, retail holding in the company has almost stayed constant
In last 3 months, foreign institutional holding of the company has almost stayed constant
RPGLIFE Shareholding Pattern
RPGLIFE Shareholding History
Mutual Funds Invested in RPGLIFE
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding RPG Life Sciences Limited
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 1.1072% | Percentage of the fund’s portfolio invested in the stock 0.43% | Change in the portfolio weight of the stock over the last 3 months 0.05% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 61/72 (-5) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 1.0659% | Percentage of the fund’s portfolio invested in the stock 1.26% | Change in the portfolio weight of the stock over the last 3 months 0.07% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 21/98 (+9) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9454% | Percentage of the fund’s portfolio invested in the stock 9.28% | Change in the portfolio weight of the stock over the last 3 months 1.40% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 9/28 (-7) |
Compare 3-month MF holding change on Screener
smallcases containing RPGLIFE stock
Looks like this stock is not in any smallcase yet.
RPGLIFE Events
RPGLIFE Dividend Trend
RPGLIFE has increased dividends consistently over the last 5 years
Current dividend yield is 0.73%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹7.28 every year
Dividends
Corp. Actions
Announcements
Legal Orders
RPGLIFE Upcoming Dividends
No upcoming dividends are available
RPGLIFE Past Dividends
Cash Dividend
Ex DateEx DateJun 28, 2024
Dividend/Share
₹16.00
Ex DateEx Date
Jun 28, 2024
Cash Dividend
Ex DateEx DateJul 21, 2023
Dividend/Share
₹12.00
Ex DateEx Date
Jul 21, 2023
Cash Dividend
Ex DateEx DateJul 14, 2022
Dividend/Share
₹9.60
Ex DateEx Date
Jul 14, 2022
Cash Dividend
Ex DateEx DateAug 13, 2021
Dividend/Share
₹7.20
Ex DateEx Date
Aug 13, 2021
Cash Dividend
Ex DateEx DateMar 24, 2020
Dividend/Share
₹4.00
Ex DateEx Date
Mar 24, 2020
RPGLIFE Stock News & Opinions
Profit before tax (PBT) gained 31.93% to Rs 46.89 crore in Q3 FY25 from Rs 35.54 crore in Q3 FY24. Total expenses added 7.53% YoY to Rs 129.13 crore during the quarter. Employee benefits expense stood at Rs 28.71 crore (down 14.78% YoY), and finance costs came in at Rs 0.12 (down 14.28% YoY). On a nine-month basis, the company's consolidated net profit tumbled 11.46% to Rs 65.89 crore despite a 12.14% increase in revenue from operations to Rs 510.34 crore in 9M FY25 over 9M FY24. RPG Life Sciences in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). Powered by Capital Market - Live
Net profit of RPG Life Sciences rose 32.01% to Rs 34.93 crore in the quarter ended December 2024 as against Rs 26.46 crore during the previous quarter ended December 2023. Sales rose 12.37% to Rs 172.71 crore in the quarter ended December 2024 as against Rs 153.70 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales172.71153.70 12 OPM %28.4624.66 - PBDT52.3539.68 32 PBT46.8935.54 32 NP34.9326.46 32 Powered by Capital Market - Live
RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 24 January 2025.Powered by Capital Market - Live
Net profit of RPG Life Sciences declined 83.76% to Rs 4.20 crore in the quarter ended September 2024 as against Rs 25.86 crore during the previous quarter ended September 2023. Sales rose 12.13% to Rs 172.21 crore in the quarter ended September 2024 as against Rs 153.58 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales172.21153.58 12 OPM %26.6724.28 - PBDT47.7039.02 22 PBT42.3934.79 22 NP4.2025.86 -84 Powered by Capital Market - Live
RPG Life Sciences will hold a meeting of the Board of Directors of the Company on 7 November 2024Powered by Capital Market - Live

Harsh Goenka-backed RPG Life Sciences surges 15% on solid Q1FY25 results


RPG Life Sciences standalone net profit rises 21.09% in the June 2024 quarter

Q2 Review: RPG Life Sciences MD On Q2 Report Card & More | BQ Prime
Over the last 5 years, revenue has grown at a yearly rate of 12.23%, vs industry avg of 9.04%
Over the last 5 years, market share stayed at 0.15%
Over the last 5 years, net income has grown at a yearly rate of 51.98%, vs industry avg of 15.28%